摘要
具有至少一个碳水化合物识别结构域的蛋白质是凝集素,能够识别和可逆地与糖结合物或可溶性碳水化合物的糖基分子相互作用。已经证明凝集素在介导信号转导、细胞识别与相互作用、免疫防御等方面起着重要的作用。大多数生物都能合成和秘密凝集素。部分与多种癌症密切相关的凝集素,即癌症凝集素,参与肿瘤的发生、生长和复发。Cancerlectins因其在实验室研究、临床诊断和治疗、给药和靶向癌症中的应用而被研究。从大量凝集素中筛选出肿瘤凝集素基因有助于肿瘤的解剖。已经建立了几种基于机器学习方法的肿瘤凝集素预测工具,并成为实验方法的一个很好的补充。在本文中,我们全面地总结和阐述了实现肿瘤凝集素预测模型所必需的材料。我们希望这一综述将有助于了解肿瘤凝集素,并为癌症凝集素的研究提供有价值的线索。新的肿瘤凝集素基因鉴定系统有望用于临床应用和基因治疗。
关键词: 肿瘤凝集素,非肿瘤凝集素,特征提取和选择,机器学习方法,PSSM,ProSite。
Current Gene Therapy
Title:A Brief Survey of Machine Learning Application in Cancerlectin Identification
Volume: 18 Issue: 5
关键词: 肿瘤凝集素,非肿瘤凝集素,特征提取和选择,机器学习方法,PSSM,ProSite。
摘要: Proteins with at least one carbohydrate recognition domain are lectins that can identify and reversibly interact with glycan moiety of glycoconjugates or a soluble carbohydrate. It has been proved that lectins can play various vital roles in mediating signal transduction, cell-cell recognition and interaction, immune defense, and so on. Most organisms can synthesize and secret lectins. A portion of lectins closely related to diverse cancers, called cancerlectins, are involved in tumor initiation, growth and recrudescence. Cancerlectins have been investigated for their applications in the laboratory study, clinical diagnosis and therapy, and drug delivery and targeting of cancers. The identification of cancerlectin genes from a lot of lectins is helpful for dissecting cancers. Several cancerlectin prediction tools based on machine learning approaches have been established and have become an excellent complement to experimental methods. In this review, we comprehensively summarize and expound the indispensable materials for implementing cancerlectin prediction models. We hope that this review will contribute to understanding cancerlectins and provide valuable clues for the study of cancerlectins. Novel systems for cancerlectin gene identification are expected to be developed for clinical applications and gene therapy.
Export Options
About this article
Cite this article as:
A Brief Survey of Machine Learning Application in Cancerlectin Identification, Current Gene Therapy 2018; 18 (5) . https://dx.doi.org/10.2174/1566523218666180913112751
DOI https://dx.doi.org/10.2174/1566523218666180913112751 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements